Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India

From March to June 2021, India experienced a deadly second wave of COVID-19, with an increased number of post-vaccination breakthrough infections reported across the country. To understand the possible reason for these breakthroughs, we collected 677 clinical samples (throat swab/nasal swabs) of ind...

Cijeli opis

Bibliografski detalji

Glavni autori:	Nivedita Gupta, Harmanmeet Kaur, Pragya Dhruv Yadav, Labanya Mukhopadhyay, Rima R. Sahay, Abhinendra Kumar, Dimpal A. Nyayanit, Anita M. Shete, Savita Patil, Triparna Majumdar, Salaj Rana, Swati Gupta, Jitendra Narayan, Neetu Vijay, Pradip Barde, Gita Nataraj, Amrutha Kumari B., Manasa P. Kumari, Debasis Biswas, Jyoti Iravane, Sharmila Raut, Shanta Dutta, Sulochana Devi, Purnima Barua, Piyali Gupta, Biswa Borkakoty, Deepjyoti Kalita, Kanwardeep Dhingra, Bashir Fomda, Yash Joshi, Kapil Goyal, Reena John, Ashok Munivenkatappa , Rahul Dhodapkar, Priyanka Pandit, Sarada Devi, Manisha Dudhmal, Deepa Kinariwala, Neeta Khandelwal, Yogendra Kumar Tiwari, Prabhat Kiran Khatri, Anjli Gupta, Himanshu Khatri, Bharti Malhotra, Mythily Nagasundaram, Lalit Dar, Nazira Sheikh, Jayanthi Shastri, Neeraj Aggarwal, Priya Abraham
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2021-09-01
Serija:	Viruses
Teme:	breakthrough COVID-19 VRDL Delta and Delta plus variant India vaccine
Online pristup:	https://www.mdpi.com/1999-4915/13/9/1782
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!